141 results
Page 4 of 8
8-K
EX-5.1
8ih7941ay2l2 1tgnn
22 Jan 20
Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares
5:30pm
8-K
EX-1.1
vqbh xbnv3
22 Jan 20
Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares
5:30pm
424B5
bxgapghxr qagce7ny4
21 Jan 20
Prospectus supplement for primary offering
5:21pm
8-K
EX-10.1
4qjiw8o5n
13 Jan 20
Adaptimmune Appoints Elliot Norry as Chief Medical Officer and Makes Changes to R&D Leadership
8:42am
8-K
EX-10.2
7hso38s vogrrspya27
13 Jan 20
Adaptimmune Appoints Elliot Norry as Chief Medical Officer and Makes Changes to R&D Leadership
8:42am
F-6EF
EX-99
0j02nk hmtjmqsrnmcyk
30 Aug 19
Automatic registration for ADRs (foreign)
1:06pm
F-6EF
fbnczp9et4ekta2w
30 Aug 19
Automatic registration for ADRs (foreign)
1:06pm
S-8
iarqgar
30 Aug 19
Registration of securities for employees
12:30pm
S-8
EX-5.1
03i 1f9c02
30 Aug 19
Registration of securities for employees
12:30pm
8-K
EX-10.1
7hd0diq7cd0yl8a2kl
27 Aug 19
Entry into a Material Definitive Agreement
8:39am
8-K
EX-10.1
reiin3kq 80uuy2si3ni
1 Aug 19
New Executive Team Announced at Adaptimmune
7:22am
8-K
EX-10.4
zlq70v8fsvb21p1nzv5
27 Jun 19
Departure of Directors or Certain Officers
8:08am
8-K
EX-10.1
3lyqz4z6h8vx9pdunly9
27 Jun 19
Departure of Directors or Certain Officers
8:08am